Veradermics, Inc. (MANE)

122.28 +13.46 (+12.37%) USD  |  NYSE  |  Oct 19, 16:00
124.00 +1.72 (+1.41%) Pre-Market: 20:00
More

Veradermics EV to Assets (Quarterly)

EV to Assets (Quarterly) Chart

View EV to Assets (Quarterly) for MANE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to Assets (Quarterly) Data

View and export this data back to 2026. Start Trial.
Date Value
June 30, 2026 --
Date Value
March 31, 2026 --

Enterprise Value Ratios (EV) Definition

Enterprise Value/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.

Read full definition.

EV to Assets (Quarterly) Range, Past 5 Years

View EV to Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Assets (Quarterly) Benchmarks

View EV to Assets (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Veru, Inc. Upgrade
Johnson & Johnson Upgrade

EV to Assets (Quarterly) Related Metrics

EV to Earnings Upgrade